Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Icon
(NASDAQ:ICLR)
Intraday
$308.31
8.23
[2.74%]
After-Hours
$308.31
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$308.31
8.23
[2.74%]
At close: Apr 26
$308.31
0
[0.00%]
After Hours: 4:00PM EDT
Get Report
Watch
Q1 2024 Earnings were released on Wed Apr 24th, after the market close
The most recent conference call was at 8:00 AM, 1 day ago
Click to view past webcast
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Icon Stock (NASDAQ:ICLR)
Icon Stock (NASDAQ: ICLR)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, April 26, 2024
TD Cowen Maintains Buy on Icon, Raises Price Target to $349
Benzinga Newsdesk
-
2 hours ago
Evercore ISI Group Maintains Outperform on Icon, Lowers Price Target to $330
Benzinga Newsdesk
-
3 hours ago
Baird Maintains Outperform on Icon, Raises Price Target to $363
Benzinga Newsdesk
-
8 hours ago
Wednesday, April 24, 2024
Icon Q1 2024 GAAP EPS $2.25 Beats $2.10 Estimate, Sales $2.09 Inline With $2.09B Estimate
Benzinga Newsdesk
-
1 day ago
Tuesday, April 16, 2024
Looking At Icon's Recent Unusual Options Activity
Benzinga Insights
-
Apr 16, 2024, 3:46PM
Friday, April 12, 2024
Here's How Much You Would Have Made Owning Icon Stock In The Last 20 Years
Benzinga Insights
-
Apr 12, 2024, 5:30PM
Thursday, April 04, 2024
Baird Maintains Outperform on Icon, Raises Price Target to $362
Benzinga Newsdesk
-
Apr 4, 2024, 1:13PM
Mizuho Reiterates Buy on Icon, Maintains $346 Price Target
Benzinga Newsdesk
-
Apr 4, 2024, 8:40AM
Wednesday, April 03, 2024
ICON Announces CFO Transition, Brendan Brennan, Will Leave His Role At Icon In Q4 This Year; Co Reaffirmed Its Previously Announced Full Year 2024 Guidance; Commenced A Search To Identify Next CFO
Benzinga Newsdesk
-
Apr 3, 2024, 4:32PM
ICON CFO Brendan Brennan To Leave Role In Q4
Benzinga Newsdesk
-
Apr 3, 2024, 4:16PM
Monday, March 25, 2024
Here's How Much You Would Have Made Owning Icon Stock In The Last 15 Years
Benzinga Insights
-
Mar 25, 2024, 10:30AM
Friday, March 08, 2024
Here's How Much $100 Invested In Icon 20 Years Ago Would Be Worth Today
Benzinga Insights
-
Mar 8, 2024, 10:30AM
Friday, February 23, 2024
If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today
Benzinga Insights
-
Feb 23, 2024, 1:00PM
Thursday, February 22, 2024
NICE Posts Upbeat Earnings, Joins FTI Consulting, NVIDIA, Moderna And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
-
Feb 22, 2024, 11:33AM
ICON shares are trading higher after the company reported better-than-expected Q4 adjusted EPS results and issued FY24 guidance.
Benzinga Newsdesk
-
Feb 22, 2024, 10:04AM
Wednesday, February 21, 2024
ICON Reaffirms FY24 EPS $14.50-$15.30 Vs $14.91 Est.; Revenue $8.4B-$8.8B Vs $8.66B Est.
Benzinga Newsdesk
-
Feb 21, 2024, 4:22PM
Icon Q4 Adj. EPS $3.46 Beats $3.45 Estimate, Sales $2.07B Miss $2.09B Estimate
Happy Mohamed
-
Feb 21, 2024, 4:18PM
Earnings Scheduled For February 21, 2024
Benzinga Insights
-
Feb 21, 2024, 5:09AM
Monday, February 12, 2024
Here's How Much $1000 Invested In Icon 20 Years Ago Would Be Worth Today
Benzinga Insights
-
Feb 12, 2024, 12:00PM
Thursday, January 25, 2024
Barclays Maintains Overweight on Icon, Raises Price Target to $325
Benzinga Newsdesk
-
Jan 25, 2024, 9:46AM
Tuesday, January 09, 2024
ICON Sees FY24 Adj. EPS $14.50-$15.30 Vs $14.86 Est.; Revenue $8.4B-$8.8B Vs $8.68B Est.
Benzinga Newsdesk
-
Jan 9, 2024, 8:17AM
Wednesday, December 20, 2023
JP Morgan Maintains Overweight on Icon, Raises Price Target to $330
Benzinga Newsdesk
-
Dec 20, 2023, 3:12PM
Friday, December 15, 2023
Truist Securities Initiates Coverage On Icon with Buy Rating, Announces Price Target of $357
Benzinga Newsdesk
-
Dec 15, 2023, 6:39AM
Monday, December 11, 2023
Citigroup Maintains Buy on Icon, Raises Price Target to $315
Benzinga Newsdesk
-
Dec 11, 2023, 7:06AM
Thursday, October 26, 2023
Icon shares are trading higher after the company reported better-than-expected Q3 results.
Benzinga Newsdesk
-
Oct 26, 2023, 10:28AM
Wednesday, October 25, 2023
Icon Q3 EPS $3.30 Beats $3.28 Estimate, Sales $2.06B Beat $2.05B Estimate
Benzinga Newsdesk
-
Oct 25, 2023, 5:11PM
Earnings Scheduled For October 25, 2023
Benzinga Insights
-
Oct 25, 2023, 7:32AM
Tuesday, October 24, 2023
Earnings Preview: Icon
Benzinga Insights
-
Oct 24, 2023, 5:00PM
Tuesday, October 17, 2023
Lennox International To Rally 22%? Here Are 10 Top Analyst Forecasts For Tuesday
Lisa Levin
-
Oct 17, 2023, 7:57AM
Baird Maintains Outperform on Icon, Raises Price Target to $287
Benzinga Newsdesk
-
Oct 17, 2023, 7:11AM
Thursday, September 14, 2023
Uber Technologies, Blackstone And A Major Healthcare Company: CNBC's 'Final Trades'
Priya Nigam
-
Sep 14, 2023, 8:52AM
Wednesday, September 13, 2023
Where Icon Stands With Analysts
Benzinga Insights
-
Sep 13, 2023, 4:00PM
CNBC Halftime Report Final Trades: Uber, Blackstone, ICON
Benzinga Newsdesk
-
Sep 13, 2023, 12:59PM
Mizuho Reiterates Buy on Icon, Maintains $274 Price Target
Benzinga Newsdesk
-
Sep 13, 2023, 11:41AM
U.S. Biomedical Advanced Research and Development Authority (BARDA) Taps ICON to Execute Next Generation COVID-19 Vaccines Clinical Trial
Benzinga Newsdesk
-
Sep 13, 2023, 7:17AM
Friday, July 28, 2023
ICON shares are trading higher after Barclays maintained an Overweight rating on the stock and raised its price target from $250 to $280.
Benzinga Newsdesk
-
Jul 28, 2023, 2:56PM
5 Analysts Have This to Say About Icon
Benzinga Insights
-
Jul 28, 2023, 8:00AM
Barclays Maintains Overweight on Icon, Raises Price Target to $280
Benzinga Newsdesk
-
Jul 28, 2023, 6:18AM
Wednesday, July 26, 2023
ICON Narrows FY23 Adjusted EPS Guidance From $12.40-$13.05 To $12.63-$12.91, Consensus $12.60
Benzinga Newsdesk
-
Jul 26, 2023, 5:13PM
ICON Narrows FY23 Revenue Range From $7.94B-$8.34B To $8.07B-$8.21B, Consensus $8.14B
Benzinga Newsdesk
-
Jul 26, 2023, 5:12PM
Icon Q2 Adj EPS $3.11 Beats $3.08 Estimate, Sales $2.02B Inline
Benzinga Newsdesk
-
Jul 26, 2023, 4:18PM
Earnings Scheduled For July 26, 2023
Benzinga Insights
-
Jul 26, 2023, 4:18AM
Friday, July 14, 2023
Deutsche Bank Maintains Buy on Icon, Raises Price Target to $300
Benzinga Newsdesk
-
Jul 14, 2023, 12:40PM
Tuesday, July 11, 2023
The Latest Analyst Ratings for Icon
Benzinga Insights
-
Jul 11, 2023, 8:09AM
Mizuho Maintains Buy on Icon, Raises Price Target to $274
Benzinga Newsdesk
-
Jul 11, 2023, 7:32AM
Monday, June 26, 2023
ICON plc Set to Join Russell 3000 Index
Benzinga Newsdesk
-
Jun 26, 2023, 6:02AM
Thursday, May 04, 2023
Will Chart Analysts Notice Bad Omen on Icon's Chart
Benzinga Insights
-
May 4, 2023, 10:48AM
Monday, May 01, 2023
Baird Maintains Outperform Rating for Icon: Here's What You Need To Know
Benzinga Insights
-
May 1, 2023, 1:00PM
Wells Fargo Maintains Equal-Weight on Icon, Lowers Price Target to $220
Benzinga Newsdesk
-
May 1, 2023, 6:50AM
Friday, April 28, 2023
Where Icon Stands With Analysts
Benzinga Insights
-
Apr 28, 2023, 2:00PM
Show more